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Abstract Natural products are compounds that are produced by living 
organisms. They have numerous applications in our everyday life, from 
antibiotics to herbicides. They possess great chemical and structural 
diversity, which gives them a leading position as a source of new drugs. 
Many institutions worldwide are focusing more and more on natural 
product research, with microorganisms and plants being the most 
common source for discovery of new compounds. On the 30th June and 1st 
July 2016, early-career scientists working in the field of natural products 
gathered at the University of Warwick for the 10th edition of the 
Chemistry and Biology of Natural Products Symposium (CBNP10). This 
critical reflection reviews, in the context of the current research in the 
field, the major considerations that arose from this meeting. 
Keywords: Natural products, specialised metabolites, antibiotics, 
herbicides, microorganisms, bioinformatics. 
 
 
Background 
Natural products are a vast pool of compounds that are biosynthesised 
by living organisms. Despite not being strictly needed for survival, they 
can offer a competitive advantage to the producing host, compared with 
organisms that live in the same environment that do not produce them. 
This is the case for compounds that possess antibacterial, insecticidal, 
herbicidal, and antinematodal properties. In other instances, however, 
natural products can have cryptic (unknown) functions in their producing 
hosts, raising important ecological questions. Overall, natural products 
represent an incredibly rich reservoir of bioactive compounds that have 
been used since the dawn of humankind for their beneficial properties.  
The 1950s and the 1960s are considered to have been the golden age of 
natural products drug discovery. Prompted by the previous discovery of 
the antibiotics penicillin and streptomycin many other life-saving 
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antibiotics were identified during this period (Umezawa, 1958; Anderson 
et al., 1961), but then a substantial slowdown followed. This was due in 
part to rediscovery of previously characterised natural products, as well 
as to an increased focus in developing semi-synthetic derivatives of 
already known natural products (e.g. ampicillin, amoxicillin, and the 
other semi-synthetic penicillins). In the last decade however, interest in 
the discovery of novel natural products has been renewed (Baltz, 2008; 
Shen, 2015).  This has been prompted by the decreasing cost of genome 
sequencing and the advances in bioinformatics and molecular biology, 
which are allowing for accurate identification of ‘promising’ gene clusters 
(aggregates of genes that cooperate towards biosynthesis of a specific 
natural product) within microbial genomes, as well as precise genome 
editing. Equally, improved analytical chemistry techniques for 
characterisation and purification of compounds have also facilitated 
identification and study of natural products. The importance of natural 
products discovery was also recognised last year by the award of the 
Nobel Prize in Physiology and Medicine to William C. Campbell, Satoshi 
Omura, and Youyou Tu for the discoveries of avermectins (from the 
bacterium Streptomyces avermitilis) and artemisinin (from plants of 
Artemisia annua L.), respectively. These two compounds have 
revolutionised the treatment of two life-threatening infectious diseases: 
river blindness and malaria. The conferment of this prize, together with 
the new technologies offered by bioinformatics, synthetic biology, and 
genomics, acknowledge the start of a new golden age of natural product 
discovery (Shen, 2015).  
The UK has emerged in this context as one of the leading countries for 
natural products research worldwide, with a growing number of 
institutions and researchers working in this field. One of the main lines of 
research undertaken by scientists in the UK is that of natural products 
discovery, which aims to find new compounds with bioactive properties 
that may be used as antibiotics, anticancer drugs and herbicides, to name 
a few. Current research in the field is focusing primarily on 
microorganisms, i.e. fungi and bacteria. These organisms exhibit several 
advantages compared for instance to plants, such as quicker replication 
times, easier genetic manipulation, and easier cultivation requirements – 
with the possibility of culture in large scale fermenters. The other main 
area of focus currently is on the biosynthesis of natural products, i.e. the 
consecutive steps that lead to the metabolite. Small molecule building 
blocks, which most often come from the primary metabolism, are 
employed in enzyme-catalysed reactions to assemble a more complex 
specialised metabolite. Typically, the aim of the research in this area is to 
find a link between the genetics and the biochemistry of the biosynthetic 
routes that lead to the natural products. Unsurprisingly, natural products 
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discovery and study of their biosynthesis were at the centre of the focus 
during the Chemistry and Biology of Natural Products Symposium at 
Warwick.  
Aim and Format of the Event 
On the 30th of June and 1st of July 2016, researchers working in the field 
of natural products gathered at the University of Warwick for the 10th 
edition of the Chemistry and Biology of Natural Products Symposium 
(CBNP10) (see Figure 1). Over the years this conference has been 
representing an opportunity for young researchers to present their work 
to an audience of experts in their field. This edition attracted 123 
participants from more than 30 different institutions from the UK and 
beyond, with approximately three quarters of participants being PhD 
students and postdoctoral researchers (see Table 1). The conference had 
a global reach - scientists from more than 20 different nationalities were 
present at the event. During the meeting, 21 talks were delivered by 
selected participants (11 from PhD students, 8 from postdoctoral 
researchers, and 2 from principal investigators), alongside more than 50 
poster presentations. The insights discussed here are only a sample of 
the work presented by the speakers during the conference, as much was 
unfinished and/or unpublished. In fact, half of the selected speakers 
were 2nd and 3rd year PhD students that were typically in the middle of 
their projects. 
 
Figure 1. Pictures from the CBNP10 at Warwick. 
Table 1. Breakdown of participants to the CBNP10 and their respective position. 
Position Participants 
PhD students 50 
Postdoctoral researchers 40 
Principal 
Investigators/Lecturers 
22 
Master students 4 
Undergraduate students 3 
Others 4 
TOTAL 123 
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Considerations emerging from the CBNP10 
As mentioned above, discovery of bioactive compounds with novel 
chemistry is one of the main themes of research within the field of 
natural products. Lately, this has been prompted by the decreasing cost 
of next-generation sequencing technologies, which facilitates acquisition 
of data from microbial genomes. Bacterial and fungal genomes can 
therefore be sequenced in a matter of weeks for few thousand pounds. 
This is providing scientists with an ever increasing amount of genomic 
data, which can be analysed through bioinformatic techniques in the 
quest for potentially ‘promising’ gene clusters. It is relatively easy 
nowadays to identify such putative gene clusters using tools like 
antiSMASH (antibiotics and Secondary Metabolite Analysis Shell) (Weber 
et al., 2015) and SMURF (Secondary Metabolite Unknown Regions 
Finder) (Khaldi et al., 2010), which in some cases return up to 50 putative 
gene clusters within one microbial genome. However, it is still a difficult 
task to predict a priori from the genomic data what the exact structure of 
the corresponding natural product will be.  
On these lines, one of the main considerations that emerged from the 
work presented at the CBNP10 was that efforts are being made to 
improve tools that allow for prediction of the chemistry of a natural 
product based on the DNA sequence of the biosynthetic genes it derives 
from. Algorithms are being developed to identify conserved DNA 
sequences within gene clusters (Medema and Fischbach, 2015), as 
discussed during the conference by Xiaowen Lu, from the bioinformatics 
group at Wageningen University (Netherlands). The increasing number of 
natural products that are being linked to their genetic counterparts, and 
the dissection of the biosynthetic gene clusters and related pathways, 
are allowing researchers to identify evolutionary conserved motifs within 
genomic sequences, which can be linked to specific conserved chemical 
moieties in the structure of the natural product. Predicting the structure 
of natural products from genomic data is therefore envisaged to become 
even easier in future, as conserved motifs within the biosynthetic 
enzymes are characterised.  
Although in silico predictions cannot yet tell us precisely what the exact 
chemical structure of a natural product is, we can still use these tools to 
discern gene clusters and select which ones to bring forward for further 
experimental studies. As highlighted in the talks and posters presented at 
the CBNP10, a significant amount of research on natural products 
discovery is currently being done with the aim of identifying new 
antibiotics and new herbicides, which could allow the development of 
novel antimicrobial agents for use in human medicine, as well as 
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agrochemicals to provide better crop protection in agriculture. Alice 
Banks and Claudio Greco, both from the University of Bristol, presented 
work that aims to characterise novel antibiotics and herbicides, 
respectively, from basidiomycete fungi – a group that has been 
overlooked for some time for discovery of natural products (Stadler and 
Hoffmeister, 2015). 
Considering that discovery of compounds with novel chemical backbones 
can be challenging, efforts are also being made to develop structural 
analogues of the already available natural products, with the aim of 
improving their bioactivity. Synthetic routes are being used to generate 
agrochemical and antibiotic precursors in sufficient amounts to then 
undergo structure–activity relationship (SAR) studies, where the 
bioactivity of the derived analogues is investigated in relation to their 
chemical structure. This was discussed for instance during the CBNP10 by 
Mairi Littleson from Allan Watson’s group at the University of 
Stratchlyde, in regards to coronatine, a phytotoxic polyketide that has 
the potential to be exploited to develop new herbicide derivatives. At 
present however, its total synthesis remains challenging – due for 
instance to stereochemical requirements – and improving current 
approaches would likely be beneficial for the consequent generation of 
structural analogues (Littleson et al., 2016).  
Synthetic routes can often not be as efficient as their biosynthetic 
counterparts, which exploit instead the catalytic activity of naturally-
occurring enzymes. The enzymes that are employed by plants or 
microorganisms in nature can in fact also be used in the laboratory to 
recreate biosynthesis of the desired natural product. Two alternative 
methods can be utilised for this purpose: either in vitro or in vivo studies. 
In vitro reactions are those where the enzymes involved in biosynthesis 
of a natural product are purified via overexpression in Escherichia coli (E. 
coli), then fed with the precursors of the natural product. Due to the low 
production yields normally obtained, the purpose of the reaction is often 
purely to characterise the catalytic activity of the enzymes. In vivo 
strategies are those where the enzymes are studied that are known to 
give the natural product of interest, which are then exploited either 
within the producing host or within another suitable and easy to culture 
microorganism, such as E. coli or the baker’s yeast Saccharomyces 
cerevisiae. To this purpose, assembly of large and complex enzymes can 
be achieved using different technologies, such as that of the newly 
developed multiplexed integrating plasmids (Fayed et al., 2015), which 
was presented during the CBNP10 by Hong Gao, from Maggie Smith’s 
group at the University of York. This approach uses phage-encoded serine 
integrases (enzymes that can cut precisely DNA and recombine it in a 
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predictable way), and its efficacy was demonstrated by cloning and 
assembling the cluster for biosynthesis of the antibiotic erythromycin. 
Conversely, in some instances, biosynthetic pathways for natural 
products include spontaneous reactions that are not catalysed by 
enzymes, but rather proceed through thermal or photochemical routes. 
This is the case, for example, for the polyketide heronamide C, which is a 
natural product with inhibitory activity against fission yeast. Thomas 
Booth, from Barrie Wilkinson’s group at the John Innes Centre, presented 
work at the CBNP10 that shows how the two consecutive intramolecular 
reactions that lead to this natural product are a thermal and a 
photochemical cycloaddition, which are independent from any enzymatic 
catalysis (Booth et al., 2016).  
It is widely recognised that understanding the biosynthetic pathway of a 
natural product is essential for its further manipulation. As discussed at 
the CBNP10, new approaches are also being developed to facilitate 
characterisation of biosynthetic pathways for natural products. For 
instance, comparative untargeted metabolomics was used to gain 
insights into the biosynthesis of the antibiotic bottromycin (Crone et al., 
2016), as presented by Andrew Truman, from the John Innes Centre. A 
network analysis of mass spectrometry data was used to assess the 
metabolite profiles of a series of mutant strains of the bacteria that 
produce the antibiotic. This allowed the key steps in the biosynthesis of 
the natural product to be elucidated. Another innovative approach used 
to characterise intermediates in biosynthesis of polyketide natural 
products was presented during the CBNP10 by Ina Wilkening, from 
Manuela Tosin’s group at the University of Warwick – chain termination 
probes (Parascandolo et al., 2016). This strategy relies on the use of 
chemical probes for capturing of intermediates, which are then analysed 
and identified by high-resolution mass spectrometry. This enables 
researchers to remove the problem of polyketide intermediates being 
covalently tethered to their enzyme factories, and therefore prevent 
detection under normal conditions. 
The approaches discussed here and conferred during the CBNP10 will 
most likely aid researchers in recreating and studying biosynthesis of 
other natural products from microorganisms and plants. This in turn will 
allow for increased yields of the compounds of interest, which can then 
be purified and used as an antibiotic, herbicide, or as an anticancer 
agent, depending on their bioactivities. At the same time, comprehensive 
studies on biosynthetic routes will also enable direction of biosynthesis 
towards different analogues with potentially enhanced bioactivities. 
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Conclusions and Forthcoming Meetings 
Natural products are a unique source of bioactive compounds, which 
have been isolated from plants and microorganisms for decades and 
exploited in a variety of ways. Despite a slowdown in natural product 
drug discovery until the last decade, it seems now evident that interest in 
identifying novel specialised metabolites to be used as pharmaceuticals 
and herbicides has been renewed. Equally, the study of biosynthetic 
processes that lead to natural products is aiding the production of 
already known bioactive compounds. Conventional synthetic approaches 
of obtaining derivatives of natural products are now being supported (or 
in some cases replaced) by enzyme-catalysed reactions, whereby the use 
of biocatalysts is envisaged to substantially reduce the cost of industrial 
chemical derivatisation. 
These and other recent advances in natural products research were 
discussed during the CBNP10, highlighting the current themes of 
investigation undertaken by prominent groups in the UK, as well as 
future perspectives on the subject. The outstanding quality of the oral 
presentations delivered by PhD students and postdoctoral researchers at 
the CBNP10 points to a brilliant and flourishing future for the study of 
natural products. The University of Warwick will host the Chemistry and 
Biology of Natural Products Symposium again at the end of June 2017, 
which will then be its 11th edition. Before this, another important 
meeting for researchers in the field of natural products will be held at 
Warwick at the end of March 2017. Our University will be the venue for 
the Directing Biosynthesis V, a meeting sponsored by the Royal Society of 
Chemistry, with world-leading invited speakers in the field of natural 
products. It now seems clear that Warwick is gaining a crucial position in 
the UK for natural products research, and one which will continue to 
thrive in the forthcoming years.  
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